Entheogens | Jotup

US Cannabis Council Elects Akerna CEO, Jessica Billingsley, as Board Chair

Retrieved on:

Wednesday, August 4, 2021

Cannabis, Cannabis smoking, Entheogens, Euphoriants, Psychoactive drugs, Drugs

Billingsley was unanimously elected as chair due to her leadership experience in the cannabis industry.

Key Points:

Billingsley was unanimously elected as chair due to her leadership experience in the cannabis industry.
To do so, USCC works hand-in-hand with Congressional leaders in Washington, DC and throughout the country to advance cannabis reform.
Billingsley was unanimously elected as chair due to her leadership experience in the cannabis industry.
"Her extensive background working in the cannabis industry and with government will greatly assist USCC in reforming cannabis policy and advancing an equitable, well-regulated cannabis industry in all fifty states.

Green Scientific Labs Announces Key Addition To Its Executive Team

Retrieved on:

Wednesday, August 4, 2021

Herbs, Entheogens, Euphoriants, Medicinal plants, Plants, Hemp, Rollout, Cannabis, Branches of biology, Human behavior

DAVIE, Fla., Aug. 4, 2021 /PRNewswire-PRWeb/ --Green Scientific Labs, a leading cannabis and hemp testing laboratory, recently announced the addition of Scott Moore to the Business Development Team.

Key Points:

DAVIE, Fla., Aug. 4, 2021 /PRNewswire-PRWeb/ --Green Scientific Labs, a leading cannabis and hemp testing laboratory, recently announced the addition of Scott Moore to the Business Development Team.
Moore will play a part in its nationwide rollout and ongoing commitment to providing industry-leading support and service to its existing and future customer base.
Paul Crage, Co-Founder and Chief Executive Officer, stated, "We are very fortunate to add someone with Scott's experience to the team.
Green Scientific Labs continues its nationwide rollout with the opening of a full-service laboratory in Phoenix, Ariz., with future locations soon to follow in the midwest and northeast regions of the country.

Catalyst Cannabis Co. Establishes First Private Sector Social Equity Incubator Pusherman Delivery

Retrieved on:

Wednesday, August 4, 2021

Herbalism, Medicinal plants, Health sciences, Medicine, Clinical medicine, Cannabis smoking, Cannabis, Entheogens, Medical cannabis

LONG BEACH, Calif., August 4, 2021 /PRNewswire-PRWeb/ -- Catalyst Cannabis Co. , a leading California-based cannabis retailer is pleased to announce the opening of their first private sector social equity incubator, Pusherman Delivery .

Key Points:

LONG BEACH, Calif., August 4, 2021 /PRNewswire-PRWeb/ -- Catalyst Cannabis Co. , a leading California-based cannabis retailer is pleased to announce the opening of their first private sector social equity incubator, Pusherman Delivery .
Co-founded by Carlos Zepeda, Pusherman Delivery marks the first and only social equity applicant run cannabis delivery business in Long Beach, CA and is one of the few private sector funded social equity incubators in the industry.
To make Pusherman Delivery a reality, Catalyst Cannabis Co. put up their delivery licence under the Eastside Catalyst location along with funding 100% of the start-up costs, compliance and workforce training.
Pusherman's incubator model is meant to give social equity applicants a pathway to start a legitimate business in the cannabis space.

Ziese Farms, Rodale Institute Launch Hemp Food Research

Retrieved on:

Wednesday, August 4, 2021

Herbs, Entheogens, Euphoriants, Medicinal plants, Hemp, Plants, Cannabis, Rodale, Human behavior, Branches of biology

Ziese Farms is a world leading hemp food company that has achieved first and only known allowances for the use of the hemp leaf for foods such as baby hemp greens.

Key Points:

Ziese Farms is a world leading hemp food company that has achieved first and only known allowances for the use of the hemp leaf for foods such as baby hemp greens.
Ziese Farms granted Rodale Institute a license to the hemp/cannabis patents for use in research during the projects.
Additionally, Panacea Plant Sciences, a cannabis biotech company, has licensed a patent for hemp cultivation to Rodale Institute and Ziese Farms for the research project.
"Ziese Farms is the pioneer in hemp leaf and food cultivation and regulatory work with the FDA," Ziese Farms founder David Heldreth said.

Pure Harvest to Supply CBD, Health and Wellness Products to Doc.U.Care, Inc.

Retrieved on:

Tuesday, August 3, 2021

Herbs, Entheogens, Euphoriants, Medicinal plants, Plants, Hemp, Cannabis, Wellness, Insurance, Articles, Alternative medicine

GREENWOOD VILLAGE, CO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Pure Harvest Corporate Group, Inc. (OTCQB: PHCG), a vertically integrated consumer products holding company focused on cutting edge plant-based nutraceuticals, recreational cannabis, hemp-derived health and wellness products and emerging industries, has signed an agreement to supply CBD products to individuals covered under self-insured corporate health and wellness plans through Third-Party Administrators.

Key Points:

Pure Harvest will supply these products and brands to the patients and then bill the TPAs self-insured companies directly.
This arrangement recognizes the ability of hemp and CBD products to support and supplement a comprehensive health and wellness plan that is covered by Employers.
I am confident that this is the next revolution in health and wellness, and we are thrilled to be in such an excellent position thanks to Pure Harvest.
Pure Harvest Corporate Group, Inc. (OTCQB: PHCG) is a vertically integrated consumer products holding company, focused on cutting edge plant-based nutraceuticals, recreational cannabis, hemp-derived health and wellness products and emerging industries.

Heights Dispensary Enters Into $60 Million Agreement to Purchase 1,200 Mullen ONE Electric Delivery Vans

Retrieved on:

Tuesday, August 3, 2021

Herbalism, Medicinal plants, Health sciences, Medicine, Clinical medicine, Cannabis, Cannabis smoking, Entheogens, Medical cannabis

Heights is a Texas company specializing in high quality legal CBD and THCa8 products online, and soon through a retail cannabis dispensary.

Key Points:

Heights is a Texas company specializing in high quality legal CBD and THCa8 products online, and soon through a retail cannabis dispensary.
Additionally, Heights will purchase 1,000 Mullen ONEs by second quarter 2025.
Were very excited that Heights Dispensary has selected Mullen to satisfy all its electric vehicle needs.
The Heights order is the second, among many other companies we are currently working on, to select Mullen as their EV provider.

Avicanna Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Peru

Retrieved on:

Tuesday, August 3, 2021

Euphoriants, Entheogens, Medicinal plants, Psychoactive drugs, Drugs, Branches of biology, Appetite stimulants, Antiemetics, Tetrahydrocannabinol, Cannabis, Medical cannabis

TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that, through its majority-owned Colombian subsidiary, Santa Marta Golden Hemp S.A.S. (“SMGH”), it has completed its first commercial export into Peru of high concentration THC, full spectrum psychoactive cannabis crude oil, marketed under Avicanna’s Aureus™ brand, to Peru.

Key Points:

Believed to be the first commercial export of psychoactive THC cannabis extract from Colombia to Peru.
(SMGH), it has completed its first commercial export into Peru of high concentration THC, full spectrum psychoactive cannabis crude oil, marketed under Avicannas Aureus brand, to Peru.
Lucas Nosiglia, President of Avicanna LATAM S.A.S., commented: We are pleased to enter the growing Peruvian market and integrate Peru into our rapidly advancing supply chain and commercial platform.
Additionally, under the Aureus brand, standardized cannabis extracts and feminized seeds are made available to cultivation, cosmetic and pharmaceutical partners around the world.

Mindset Files International Patent Application for its Novel Psilocybin Synthesis Method

Retrieved on:

Tuesday, August 3, 2021

Entheogens, Psychoactive drugs, Psychoactive fungi, Mycotoxins, Organophosphates, Psilocybin

TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE:MSET) (FSE:9DF) (OTCQB:MSSTF) (Mindset or the Company), a drug discovery and development company focused on creating optimized next-generation psychedelic medicines to treat neurological and neuropsychiatric disorders with unmet medical needs, today announced that it has filed an international patent application for its novel psilocybin synthesis method.

Key Points:

TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE:MSET) (FSE:9DF) (OTCQB:MSSTF) (Mindset or the Company), a drug discovery and development company focused on creating optimized next-generation psychedelic medicines to treat neurological and neuropsychiatric disorders with unmet medical needs, today announced that it has filed an international patent application for its novel psilocybin synthesis method.
The application claims the priority date of the Companys previously filed United States Patent and Trade Office provisional application, filed on July 24, 2020.
The patent application covers Mindsets Synthesis Process, a ground-breaking process to synthesize psilocybin and psilocintwo of the known active compounds in psychedelic mushrooms.
We believe that our proprietary synthesis process is likely the most cost-effective method available in the marketplace today for cGMP grade psilocybin.

InvestorBrandNetwork Announces The Dealmaker Show Interview with Tryp Therapeutics Inc. CEO Greg McKee

Retrieved on:

Tuesday, August 3, 2021

Health sciences, Hallucinations, Psychedelic drugs, Entheogens, Psilocybin, Pharmaceutical industry, Psychoactive drugs, Pharmaceutical sciences

During the interview, Klaff asked why the company focuses on psychedelics, how McKee got involved with Tryp and what opportunities the company sees in the psychedelics space.

Key Points:

During the interview, Klaff asked why the company focuses on psychedelics, how McKee got involved with Tryp and what opportunities the company sees in the psychedelics space.
There are a lot of naturally derived chemistries around that eventually find their way into more traditional drug development pathways.
Since then, several respected academics at NYU, Johns Hopkins, Yale University and others have been studying these compounds.
Tryp Therapeutics is a pharmaceutical company focused on developing psilocybin-based compounds for the treatment of diseases with unmet medical needs through accelerated regulatory pathways.

Cornbread Hemp, Family-Owned CBD Startup, Takes Aim at Big CBD With Disruptive Video

Retrieved on:

Tuesday, August 3, 2021

Cornbread Hemp, a USDA-certified organic CBD brand, is challenging the CBD industry by introducing its Flower-Only full spectrum CBD product line in a new video, timed for National CBD Day on August 8.

Key Points:

Cornbread Hemp, a USDA-certified organic CBD brand, is challenging the CBD industry by introducing its Flower-Only full spectrum CBD product line in a new video, timed for National CBD Day on August 8.
This family-owned CBD startup takes aim at Americas biggest CBD brands by offering consumers a higher quality product than the current industry standard.
The video uses orange juice as a metaphor to educate consumers on the difference between Flower-Only and whole-plant CBD products.
Cornbread Hemp pioneered its Flower-Only process by exclusively using the flower of the hemp plant to create its superior CBD products.